CN101491626B - Traditional Chinese medicine composition for treating skin injury and pyogenic infection - Google Patents
Traditional Chinese medicine composition for treating skin injury and pyogenic infection Download PDFInfo
- Publication number
- CN101491626B CN101491626B CN2008102273582A CN200810227358A CN101491626B CN 101491626 B CN101491626 B CN 101491626B CN 2008102273582 A CN2008102273582 A CN 2008102273582A CN 200810227358 A CN200810227358 A CN 200810227358A CN 101491626 B CN101491626 B CN 101491626B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- traditional chinese
- portions
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating wound and preventing suppurative infection of skin. The traditional Chinese medicine composition is characterized in that: the traditional Chinese medicine composition is prepared from the following material medicines in portion by weight: 80 to 200 portions of amoorcorn tree bark, 5 to 70 portions of prepared rhubarb, 30 to 80 portions of radices pseudoginseng, 20 to 70 portions of cortex dictam, 20 to 70 portions of gypsum ustum, and 5 to 50 portions of dragon's blood. The traditional Chinese medicine composition has the advantages that: all components are traditional Chinese medicines which are wide in source and relatively low in price. The traditional Chinese medicine composition can be used as powder or membrane agent which is conveniently taken. The traditional Chinese medicine composition also has the advantages of simple preparation process, less necessary equipment and easy operation, and can effectively stop blood, alleviate pain, quickly promote tissue regeneration, has strong effect of adsorption antiphlogosis, is easy to use clinically and can treat the suppurative infection.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of treating skin injury, suppurative infection, belong to technical field of Chinese medicines.
Background technology
Skin injury is common traumatic disease, mainly because of colliding, impact, drop or fallen from height, with pain, hemorrhage be characteristic, the deep tissue damage can appear in severe patient.If skin is damaged the wound that caused untimely healing, thereby can be made skin purulent infection by bacteria attack, can bring huge misery to the patient.
Being used to treat the wound that skin injury causes at present, mainly is to take or inject the antibiotic medicine, wound is carried out modes such as dressing change, but all exist uncertain therapeutic efficacy to cut, or slow curative effect and cause treatment time long, expense is high.
Summary of the invention
Technical problem to be solved by this invention is, a kind of Chinese medicine composition of treating skin injury, suppurative infection.
For solving the problems of the technologies described above; The invention discloses a kind of Chinese medicine composition of treating skin injury, suppurative infection; It is characterized in that, process: Cortex Phellodendri 80-200 part, Radix et Rhizoma Rhei (processed) 5-70 part, Radix Notoginseng 30-80 part, Cortex Dictamni 20-70 part, Gypsum Fibrosum Preparatum 20-70 part, Sanguis Draxonis 5-50 part by the crude drug of following ratio of weight and number.
The Chinese medicine composition of said treatment skin injury, suppurative infection; It is characterized in that, process: Cortex Phellodendri 100-180 part, Radix et Rhizoma Rhei (processed) 10-60 part, Radix Notoginseng 40-70 part, Cortex Dictamni 30-60 part, Gypsum Fibrosum Preparatum 30-60 part, Sanguis Draxonis 10-40 part by the crude drug of following ratio of weight and number.
The Chinese medicine composition of said treatment skin injury, suppurative infection; It is characterized in that, process: Cortex Phellodendri 130-150 part, Radix et Rhizoma Rhei (processed) 25-45 part, Radix Notoginseng 50-60 part, Cortex Dictamni 40-50 part, Gypsum Fibrosum Preparatum 40-50 part, Sanguis Draxonis 20-30 part by the crude drug of following ratio of weight and number.
The Chinese medicine composition of said treatment skin injury, suppurative infection is characterized in that, is processed by the crude drug of following ratio of weight and number: 140 parts of Cortex Phellodendris, 35 parts of Radix et Rhizoma Rhei (processed), 55 parts of Radix Notoginseng, 45 parts of Cortex Dictamni, 45 parts of Gypsum Fibrosum Preparatum, 25 parts of Sanguis Draxonis.
The Chinese medicine composition of said treatment skin injury, suppurative infection is characterized in that, processes powder or membrane.
The Chinese medicine composition of said treatment skin injury, suppurative infection, the preparation method characteristic of its powder is: with Cortex Phellodendri, Radix Et Rhizoma Rhei, Radix Notoginseng; Cortex Dictamni, Gypsum Fibrosum Preparatum is weighed and is assorted by the prescription requirement; Oven dry (80～100 ℃) was pulverized 100 mesh sieves with pulverizer, Sanguis Draxonis is added pulverized 120 mesh sieves in the above-mentioned fine powder jointly again; Sterilize with ultraviolet, be sub-packed in the bottle, loading amount is the 1g/ bottle. put dry Liang Chu and preserve subsequent use.
The invention has the advantages that: composition all is a Chinese medicine, and the medicine source is sufficient, and price is relatively cheap.Chinese medicine composition of the present invention can be powder or membrane, taking convenience; Chinese medicine composition preparation technology of the present invention is simple, and equipment needed thereby is few, processing ease; It is fast that Chinese medicine composition of the present invention is imitated the hemostasis and pain-relieving granulation promoting, and stronger absorption antiinflammation is arranged, and clinical application is simple, the treatment suppurative infection.
The specific embodiment
Below come further to set forth the beneficial effect of medicine of the present invention through Test Example.
The clinical observation of embodiment 1, drug powder of the present invention:
This organizes 149 examples, male's 112 examples wherein, women's 37 examples, maximum age 65 years old, minimal ages 4 years old, 25 years old mean age, fresh wound 106 examples, pyogenic infection 40 examples, cureless wound 3 examples.
Method for using: fresh wound spreads on this powdered medicine on the wound after carrying out debridement and sewing up in right amount, changes one time medicine in 2-3 days.Pyogenic infection, cureless wound, carry out the debridement evacuation of pus after, this powder is spread on the wound in right amount, changed one time medicine in 1-3 days.
Conclusion: recovery from illness in 2-3 days after the disposable medicine-feeding after 65% the wound debridement, 2 medicine-feeding backs recovery from illness in 3-5 days after 20% the wound debridement, 3 medicine-feeding backs recovery from illness in 6-10 days after 10% the wound debridement; After 5% large tracts of land, the dark 2-3 degree wound debridement; Need repeatedly add medicine to until recovery from illness, to fresh wound, use this medicine after; Stop pain relief in oozing of blood or sepage a few minutes; Pyogenic infection, cureless wound are looked the state of an illness, use this medicine after, sepage in general several hours, ooze pus and stop, inflammation disappears gradually after several days, wound dwindles;
The preparation technology of embodiment 2, drug powder of the present invention is following:
With 140 parts of Cortex Phellodendris, 35 parts of Radix et Rhizoma Rhei (processed), 55 parts of Radix Notoginseng; 45 parts of Cortex Dictamni, Gypsum Fibrosum Preparatum is assorted for 45 parts, oven dry (80～100 ℃); Pulverized 100 mesh sieves with pulverizer, and Sanguis Draxonis was added in the above-mentioned fine powder for 25 parts pulverized 120 mesh sieves jointly again, sterilized with ultraviolet; Be sub-packed in the bottle, loading amount is the 1g/ bottle. put dry Liang Chu and preserve subsequent use.
Claims (5)
1. Chinese medicine composition of treating skin injury, suppurative infection; It is characterized in that, process: Cortex Phellodendri 80-200 part, Radix et Rhizoma Rhei (processed) 5-70 part, Radix Notoginseng 30-80 part, Cortex Dictamni 20-70 part, Gypsum Fibrosum Preparatum 20-70 part, Sanguis Draxonis 5-50 part by the crude drug of following ratio of weight and number.
2. Chinese medicine composition according to claim 1 is characterized in that, is processed by the crude drug of following ratio of weight and number: Cortex Phellodendri 100-180 part, Radix et Rhizoma Rhei (processed) 10-60 part, Radix Notoginseng 40-70 part, Cortex Dictamni 30-60 part, Gypsum Fibrosum Preparatum 30-60 part, Sanguis Draxonis 10-40 part.
3. Chinese medicine composition according to claim 1 is characterized in that, is processed by the crude drug of following ratio of weight and number: Cortex Phellodendri 130-150 part, Radix et Rhizoma Rhei (processed) 25-45 part, Radix Notoginseng 50-60 part, Cortex Dictamni 40-50 part, Gypsum Fibrosum Preparatum 40-50 part, Sanguis Draxonis 20-30 part.
4. Chinese medicine composition according to claim 1 is characterized in that, is processed by the crude drug of following ratio of weight and number: 140 parts of Cortex Phellodendris, 35 parts of Radix et Rhizoma Rhei (processed), 55 parts of Radix Notoginseng, 45 parts of Cortex Dictamni, 45 parts of Gypsum Fibrosum Preparatum, 25 parts of Sanguis Draxonis.
5. according to each described Chinese medicine composition among the claim 1-4, it is characterized in that, process powder or membrane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102273582A CN101491626B (en) | 2008-11-27 | 2008-11-27 | Traditional Chinese medicine composition for treating skin injury and pyogenic infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102273582A CN101491626B (en) | 2008-11-27 | 2008-11-27 | Traditional Chinese medicine composition for treating skin injury and pyogenic infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101491626A CN101491626A (en) | 2009-07-29 |
| CN101491626B true CN101491626B (en) | 2012-04-25 |
Family
ID=40922526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102273582A Expired - Fee Related CN101491626B (en) | 2008-11-27 | 2008-11-27 | Traditional Chinese medicine composition for treating skin injury and pyogenic infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101491626B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670810A (en) * | 2012-05-31 | 2012-09-19 | 王永红 | Drug for treating burn and preparing method thereof |
| CN103285239B (en) * | 2013-06-05 | 2015-04-01 | 吕新怀 | Traumatic |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1397321A (en) * | 2002-04-18 | 2003-02-19 | 王广顺 | Prescription and preparing process for compound spanishneedles ointment |
-
2008
- 2008-11-27 CN CN2008102273582A patent/CN101491626B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1397321A (en) * | 2002-04-18 | 2003-02-19 | 王广顺 | Prescription and preparing process for compound spanishneedles ointment |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101491626A (en) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101569696A (en) | Chinese medicament for traumatic wound | |
| CN102283969A (en) | Ointment for pressure sores | |
| CN102688383A (en) | Traditional Chinese medicine composite for treating body surface ulcer or fester | |
| CN101491626B (en) | Traditional Chinese medicine composition for treating skin injury and pyogenic infection | |
| CN102579709B (en) | Scar preventing and removing burn oil and preparation method thereof | |
| CN101716268A (en) | Powder for treating non-healing wound and bedsore | |
| CN103705735A (en) | Traditional Chinese medicine powder for stopping bleeding and diminishing inflammation | |
| CN103223077B (en) | Traditional Chinese medicine composition for treating burn and scald | |
| CN1194708C (en) | Process for preparing staltic medicine from Taiwan Beautyberry leaf | |
| CN105030958A (en) | Pharmaceutical composition and application thereof | |
| CN105560620A (en) | Trauma treatment traditional Chinese medicine preparation | |
| CN102028875B (en) | Medicament for treating open wound and preparation method thereof | |
| CN1051236C (en) | Styptic powder | |
| CN104524222A (en) | Traditional Chinese medicine for promoting wound healing | |
| CN101632803B (en) | Stancher and preparation method thereof | |
| CN101361842A (en) | Chinese herbal medicine liquid medicine for treating burn and scald | |
| CN1125139A (en) | Antiphlogistic analgesic ointment for treating burn | |
| CN1876085A (en) | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN102920824B (en) | Liniment for treating bedsore and preparation method thereof | |
| CN104474188A (en) | Chinese herbal medicine oil for treating bedsore | |
| CN103349717A (en) | Compound medicine for treating difficult-to-heal wounds, multiple wounds and suppurative diseases | |
| CN102813828B (en) | Stropanthus divericatus for treating external wounds | |
| CN103349689B (en) | Drug for treating ulcers and sores | |
| CN100356926C (en) | Ointment medicine for treating bedsore |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120425 Termination date: 20141127 |
|
| EXPY | Termination of patent right or utility model |